Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |